Judge Rules Against Teva In Case Over Generic Univasc

Law360, New York (January 6, 2005, 12:00 AM EST) -- A federal district court has ruled that Teva Pharmaceuticals’s generic moexipril infringes a patent for the hypertension drug Univasc.

Earlier this week, German drug maker Schwarz Pharma was granted summary judgment by the U.S. District Court for the District of New Jersey on its claim that Israli generics maker Teva’s drug infringes U.S. Patent No 4,743,450.

The infringement action in the District of New Jersey may now proceed to the damages phase, the drug maker said in a statement.

“We now intend to vigorously pursue its...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.